Literature DB >> 28089675

Burden of Clostridium difficile infection: Associated hospitalization in a cohort of middle-aged and older adults.

Yingxi Chen1, Kathryn Glass1, Bette Liu2, Rosemary J Korda1, Thomas V Riley3, Martyn D Kirk4.   

Abstract

BACKGROUND: Clostridium difficile is the principal cause of infectious diarrhea in hospitalized patients. The aim of this study was to describe and compare length of stay (LOS), costs, and in-hospital deaths for C difficile infection (CDI) and non-CDI hospitalizations, in a cohort of middle-aged and older Australians.
METHODS: We used survey data from the 45 and Up Study, linked to hospitalization and death data. We calculated the average LOS and costs per hospitalization, and the proportion of in-hospital deaths for CDI and non-CDI hospitalizations. We then compared hospitalizations with CDI as a secondary diagnosis to non-CDI hospitalizations by stratifying hospitalizations based on principal diagnosis and then using generalized linear models to compare LOS and in-hospital costs, and logistic regression for in-hospital deaths, adjusting for age and sex.
RESULTS: There were 641 CDI hospitalizations during 2006-2012. The average LOS was 17 days; the average cost per hospitalization was AUD 12,704; and in 7.3% of admissions (47 out of 641) the patient died. After adjusting for age and sex, hospitalizations with CDI were associated with longer LOS, higher costs, and a greater proportion of in-hospital deaths compared with hospitalizations with similar principal diagnosis but without CDI.
CONCLUSIONS: CDI places additional burden on the Australian hospital system, with CDI patients having relatively lengthy hospital stays and high costs.
Copyright © 2017 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CDI; Cost; In-hospital death; Length of stay

Mesh:

Year:  2017        PMID: 28089675     DOI: 10.1016/j.ajic.2016.12.006

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  6 in total

1.  Antimicrobial Susceptibilities of Clostridium difficile Isolates from 12 Asia-Pacific Countries in 2014 and 2015.

Authors:  Tanya Lew; Papanin Putsathit; Kyung Mok Sohn; Yuan Wu; Kentaro Ouchi; Yoshikazu Ishii; Kazuhiro Tateda; Thomas V Riley; Deirdre A Collins
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

2.  Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a University Hospital in Central China.

Authors:  Chunhui Li; Juping Duan; Sidi Liu; Xiujuan Meng; Chenchao Fu; Cui Zeng; Anhua Wu
Journal:  Infection       Date:  2017-05-11       Impact factor: 3.553

3.  In vivo efficacy of auranofin in a hamster model of Clostridioides difficile infection.

Authors:  Nader S Abutaleb; Mohamed N Seleem
Journal:  Sci Rep       Date:  2021-03-29       Impact factor: 4.379

4.  The Economic Burden of Clostridioides difficile in Denmark: A Retrospective Cohort Study.

Authors:  Uffe Christian Braae; Frederik Trier Møller; Rikke Ibsen; Steen Ethelberg; Jakob Kjellberg; Kåre Mølbak
Journal:  Front Public Health       Date:  2020-11-26

5.  Healthcare-associated Clostridium difficile infection: role of correct hand hygiene in cross-infection control.

Authors:  R Ragusa; G Giorgianni; L Lupo; A Sciacca; S Rametta; M La Verde; S Mulè; M Marranzano
Journal:  J Prev Med Hyg       Date:  2018-06-01

6.  Change in the Mortality Trend of Hospitalized Patients with Clostridium difficile Infection: A Nation-wide Study.

Authors:  Mubeen Khan Mohammed Abdul; Sanjay Bhandari
Journal:  Cureus       Date:  2020-01-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.